Mizuho raised the firm’s price target on HCA Healthcare (HCA) to $505 from $475 and keeps an Outperform rating on the shares. The firm says the company reported a good quarter.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare: Hold Rating Amid Limited Growth Potential and Policy Uncertainties
- HCA Healthcare price target raised to $475 from $465 at KeyBanc
- HCA Healthcare: Strong Financial Performance and Strategic Growth Drive Buy Rating
- HCA Healthcare Reports Strong Q3 Earnings Growth
- Midday Fly By: Intel, Ford report Q3 beats